C-reactive protein and cardiovascular risk: more fuel to the fire.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. Hemoglobin-to-Red-Cell Distribution Width Ratio Is a Novel Predictor of Long-Term Patient Outcomes After Percutaneous Coronary Intervention: A Retrospective Cohort Study.Frontiers in cardiovascular medicine · 2022
   Article
2. Sortilin and Homocysteine as Potential Biomarkers for Coronary Artery Diseases.International journal of general medicine · 2021
   Article
3. Coronary tortuosity is associated with an elevated high-sensitivity C-reactive protein concentration and increased risk of ischemic stroke in hypertensive patients.The Journal of international medical research · 2018
   Article
4. Annual decline in pentraxin 3 is a risk of vascular access troubles in hemodialysis patients.International journal of nephrology · 2014
   Article
5. Inflammatory and prothrombotic parameters in normotensive non-diabetic obese women: effect of weight loss obtained by gastric banding.Internal and emergency medicine · 2012
   Article
6. Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models.Statistics in medicine · 2012
   Article
7. Association between obesity, high-sensitivity C-reactive protein ≥2 mg/L, and subclinical atherosclerosis: implications of JUPITER from the Multi-Ethnic Study of Atherosclerosis.Arteriosclerosis, thrombosis, and vascular biology · 2011
   Article
8. Lipid parameters for measuring risk of cardiovascular disease.Nature reviews. Cardiology · 2011
   Review
9. Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3.Haematologica · 2011
   Article

Corrections and comments

• Commented on by
  C-reactive protein measurement and cardiovascular disease.2010
• Comment on
  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.2010

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as